<scp>GLP</scp> ‐1 medication and weight loss: Barriers and motivators among 1659 participants managed in a virtual setting
These findings underscore the importance of addressing patient-specific motivators and barriers during consultations to optimise outcomes and ensure sustainable weight loss strategies in clinical practice. Tailored approaches to GLP-1 treatment plans and support can help ensure sustainable weight loss strategies and improve patient adherence in clinical practice.
Authors
- Catriona M. Maybury (ORCID: https://orcid.org/0000-0001-5860-3785)
- Ehtasham Ahmad (ORCID: https://orcid.org/0000-0002-1359-9337)
- Maneeha Naveed
- Cynthia M. Pérez (ORCID: https://orcid.org/0000-0003-2529-7042)
- Laura Russell (ORCID: https://orcid.org/0009-0003-2194-1395)
- Zoe Lees
Institutions
- University Hospitals of Leicester NHS Trust (GB)
- University of Sheffield (GB)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-04-21
- DOI
- https://doi.org/10.1111/dom.16405
- Citations
- 9
- Primary Topic
- Pharmacology and Obesity Treatment
- Type
- article
- Field-Weighted Citation Impact
- 12.55